These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9219197)

  • 1. Health state utility anchors: being clear on what "1" means.
    O'Brien BJ
    Med Decis Making; 1997; 17(3):352-3. PubMed ID: 9219197
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of cost-effectiveness analysis to multiple products: a practical guide.
    Bala MV; Zarkin GA
    Am J Manag Care; 2002 Mar; 8(3):211-8. PubMed ID: 11915971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in Using MCDA for Reimbursement Decisions on New Medicines?
    Walker A
    Value Health; 2016; 19(2):123-4. PubMed ID: 27021744
    [No Abstract]   [Full Text] [Related]  

  • 4. Estimating CE ratios under second-order uncertainty: the mean ratio versus the ratio of means.
    Stinnett AA; Paltiel AD
    Med Decis Making; 1997; 17(4):483-9. PubMed ID: 9343807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longevity bias in cost-effectiveness analysis.
    Liu L; Rettenmaier AJ; Saving TR
    Health Econ; 2008 Apr; 17(4):523-34. PubMed ID: 17990284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis without treatment as a modifier in health economic assessments.
    Camidge R; Walker A; Oliver JJ; Nussey F; Maxwell S; Jodrell D; Webb DJ
    BMJ; 2005 Jun; 330(7504):1382-4. PubMed ID: 15947403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dollars may not buy as many QALYs as we think: a problem with defining quality-of-life adjustments.
    Fryback DG; Lawrence WF
    Med Decis Making; 1997; 17(3):276-84. PubMed ID: 9219187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How much are Americans willing to pay for a quality-adjusted life year?
    Weinstein MC
    Med Care; 2008 Apr; 46(4):343-5. PubMed ID: 18362811
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A second opinion. Cost-utility analysis and varying preferences for health.
    Mooney G; Jan S
    Health Policy; 1997 Sep; 41(3):201-3; discussion 203-5. PubMed ID: 10170089
    [No Abstract]   [Full Text] [Related]  

  • 11. What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?
    Braithwaite RS; Meltzer DO; King JT; Leslie D; Roberts MS
    Med Care; 2008 Apr; 46(4):349-56. PubMed ID: 18362813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [QALY or willingness to pay?].
    Steurer J
    Praxis (Bern 1994); 1999 Feb; 88(8):333-8. PubMed ID: 10097643
    [No Abstract]   [Full Text] [Related]  

  • 13. Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations.
    Higgins AM; Harris AH
    Crit Care Clin; 2012 Jan; 28(1):11-24, v. PubMed ID: 22123096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on cost-value analysis.
    Østerdal LP
    Health Econ; 2003 Mar; 12(3):247-50; discussion 251-3. PubMed ID: 12605468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DH register of cost-effectiveness studies: content and quality.
    Mason J; Drummond M
    Health Trends; 1995; 27(2):50-6. PubMed ID: 10153159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of lifestyle interventions in the Netherlands.
    Rappange DR; Brouwer WB
    Health Econ Policy Law; 2012 Apr; 7(2):243-61. PubMed ID: 22380875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a broader view of values in cost-effectiveness analysis of health.
    Menzel P; Gold MR; Nord E; Pinto-Prades JL; Richardson J; Ubel P
    Hastings Cent Rep; 1999; 29(3):7-15. PubMed ID: 10420299
    [No Abstract]   [Full Text] [Related]  

  • 18. Should we aggregate relative or absolute changes in QALYs?
    Johannesson M
    Health Econ; 2001 Oct; 10(7):573-7. PubMed ID: 11747040
    [No Abstract]   [Full Text] [Related]  

  • 19. Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.
    Marsh K; IJzerman M; Thokala P; Baltussen R; Boysen M; Kaló Z; Lönngren T; Mussen F; Peacock S; Watkins J; Devlin N;
    Value Health; 2016; 19(2):125-37. PubMed ID: 27021745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [QALYs and fairness: health economic approaches to the fairness issue and their problems].
    Klonschinski A; Lübbe W
    Gesundheitswesen; 2011 Oct; 73(10):688-95. PubMed ID: 21259190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.